Ekeren, Belgium

Lieve Declerq

This inventor holds 1 USPTO granted patent. Top assignee: E-L Management Corporation. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lieve Declerq: Innovator in Cosmetic and Pharmaceutical Compositions

Introduction

Lieve Declerq, an accomplished inventor based in Ekeren, Belgium, has made significant strides in the field of cosmetic and pharmaceutical sciences. With one patent to her name, Declerq is dedicated to enhancing the quality of skincare products through innovative research and development.

Latest Patents

Declerq's notable patent focuses on "Compositions containing mimosa phenolic compounds." This invention pertains to topical cosmetic and pharmaceutical compositions intended to enhance collagen levels in skin cells. The innovative formulations consist of biologically active phenolic compound-containing extracts, demonstrating her commitment to advancing skincare technology.

Career Highlights

Lieve Declerq is currently associated with E-L Management Corporation, where she applies her expertise to develop leading-edge cosmetic solutions. Her contributions to the company reflect her dedication to innovation in the beauty and healthcare industries.

Collaborations

Throughout her career, Declerq has collaborated with talented individuals, including her coworker Jon Anderson. These collaborations foster a dynamic environment that emphasizes creativity and progress, contributing to the successful development of groundbreaking products.

Conclusion

In conclusion, Lieve Declerq's innovative work in creating compositions that enhance collagen levels marks her as a significant figure in the cosmetic and pharmaceutical sectors. With her patent and ongoing contributions at E-L Management Corporation, she continues to influence and inspire advancements in skincare technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…